Developed in response to a preventable issue in clinical care, the SureflO2 indicator provides clear visual confirmation of gas flow to patients requiring supplemental oxygen, while mitigating the risk of disease transmission from the patient to the healthcare worker.
Headquarter Australia |
Countries of operation Australia |
Funding status Private |
Company type SME |
Research Development Project Lead
Job title | Name | Email | Country based in | Job Function | Seniority | |
---|---|---|---|---|---|---|
Research Development Project Lead | hidden.item | hidden.item | hidden.item |